Moldova Pharmaceuticals & Healthcare Q1 2021
Key View:
Due to unfavourable demographics, small market size and operational risk, Moldova offers limited opportunities in theway of pharmaceuticals and healthcare. The government's preference for generic drugs over patented drugs - as evidenced in theformer's much larger market share - limits investment opportunities although this does offer better and wider access to medication.
- Key View
- Moldova Pharmaceuticals & Healthcare Covid-19 Impact
- SWOT
- Industry Forecast
- Pharmaceutical Market Forecast
- Healthcare Market Forecast
- Prescription Drug Market Forecast
- Patented Drug Market Forecast
- Generic Drug Market Forecast
- OTC Medicine Market Forecast
- Pharmaceutical Trade Forecast
- Industry Risk/Reward Index
- Central And Eastern Europe Innovative Pharmaceuticals Risk/Reward Index
- Innovative Pharmaceuticals & Healthcare Risk/Reward Index
- Regulatory Development
- Regulatory Review
- Market Overview
- Competitive Landscape
- Company Profile
- Farmaco
- Moldova Demographic Outlook
- Pharmaceuticals & Healthcare Glossary
- Pharmaceuticals & Healthcare Methodology
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook